AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Research & development

Digital innovation is unlocking new pharmaceutical research horizons

Transforming R&D: Digital innovation in the pharmaceuticals and chemicals industries, a new report by MIT Technology Review Insights, explores how leading pharmaceuticals and chemicals companies are using artificial intelligence, quantum computing, and other digital technologies to transform scientific research and enhance R&D performance. The report, produced in association with PerkinElmer… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Biopharmaceutical #Laboratory data

IDBS and Scitara form lab technology partnership

IDBS, innovator in Biopharmaceutical Lifecycle Management (BPLM), and Scitara, laboratory IoT expert, have partnered to create a solution that aims to extend IDBS Polar BPLM’s laboratory data connectivity and instrument integration capabilities. This integrated solution augments the Polar workflow capabilities , says IDBS, by addressing the challenge of sharing and… Read More

#News

#AI / data analytics / healthtech / informatics #Pharmaceuticals

New AI-powered platform aims to revolutionise pharma marketing

PatientMetRx, an AI-powered social intelligence service from UK data tech company Talking Medicines, has been launched, to give the drug brands insights on patient experience on a scale and depth never previously possible. Specialists in social intelligence for the pharmaceutical industry, Talking Medicines developed PatientMetRx to provide a systematic way… Read More

#News

#AI / data analytics / healthtech / informatics

Using digital technology to solve compound management problems

Managing Director of Ziath, Neil Benn MSc, explains to Lu Rahman how the latest mobile and internet-enabled technologies will impact the science of compound management. Ziath is a UK-based company specialising in design, development and production of instrumentation for sample management. Ziath’s primary product range is 2D barcode scanners for… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Business #Drug development #Drug discovery #Narrated podcasts

The Business Side of Drug Discovery

Today’s episode on the topic of The Business Side of Drug Discovery, covers 3 articles taken from the most recent Fall issue of DDW. These articles are titled: Building the foundations for post COVID-19 R&D, Opportunity Knocks: Why compound screening libraries are worth the investment, and How to achieve data driven R&D at speed… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Drug discovery

NovAliX partners with Chemical.AI to develop artificial intelligence toolkit for drug discovery

NovAliX, a drug discovery-focused contract research organisation (CRO), and Chemical.AI, an artificial intelligence (AI) company leveraging human expertise and cutting-edge AI technology for chemistry and pharmaceuticals, have created a strategic It is hoped that the affiliation will help create the most relevant AI solutions for drug developers. NovAliX brings 20… Read More

#Editor's Choice #News #Trending News

#AI / data analytics / healthtech / informatics #Assay development optimisation & technology #Drug development #Drug discovery #Narrated podcasts #Research

Innovation and Opportunity in Drug Discovery

Today’s episode on the topic of Innovation and Opportunity in Drug Discovery, covers 3 articles taken from the most recent Fall issue of DDW. These articles are titled: Japanese drug development: Where is the innovation, Where are the opportunities in global drug discovery, and New for Old: The value behind drug repurposing. These… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Drug discovery

Precision medicine in the era of artificial intelligence

Dr Lotfi Chouchane and Dr. Javaid Sheikh, Weill Cornell Medicine-Qatar, outline the challenges and opportunities ahead for drug discovery Precision medicine is an emerging model for the next generation of clinical care that will capitalise on the dynamic interaction between individual biology, lifestyle, behaviour, and environment. It holds huge promise… Read More

#Exclusive Content #News #Trends & Analysis

#AI / data analytics / healthtech / informatics #Biotechnology

Intelligent thinking: the biotech business harnessing the power of AI

Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Therapeutics

Boehringer Ingelheim and Google in R&D partnership

Boehringer Ingelheim has entered a collaborative agreement with Google Quantum AI (Google), focusing on researching and implementing cutting-edge use cases for quantum computing in pharmaceutical research and development (R&D), specifically including molecular dynamics simulations. The new partnership combines Boehringer Ingelheim’s leading expertise in the field of computer-aided drug design and… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Genes

Researchers use deep learning to identify gene regulation at single-cell level

Scientists at the University of California, Irvine have developed a new deep-learning framework that predicts gene regulation at the single-cell level. Deep learning, a family of machine-learning methods based on artificial neural networks, has revolutionized applications such as image interpretation, natural language processing and autonomous driving. In a study published… Read More

#Editor's Choice #News

#AI / data analytics / healthtech / informatics #Biologics #Drug discovery #Pharmaceuticals

Is the pharmaceutical industry ready to listen directly to patients?

Dr Elizabeth Fairley, COO and co-founder of social intelligence company Talking Medicines, explains how technology has shaped the drug landscape and why actually listening to patients might be the breakthrough the industry needs. There are more drugs on the market today than ever before and the drug pipeline is massively… Read More

#Editor's Choice #News #Opinion

#AI / data analytics / healthtech / informatics #Clinical trials

Healthtech specialist Novadiscovery teams up with with Janssen France

Novadiscovery, a healthtech company offering the clinical trial simulation platform, Jinkō, to predict drug efficacy and optimize clinical trial development, has entered into a collaboration with Janssen France to provide in silico based decision support for its clinical development pipeline. Novadiscovery is committed to working with forward-looking industry leaders to… Read More

#News

#AI / data analytics / healthtech / informatics #Antibodies #Biotechnology #Cancer research #Drug development #Oncology

AI-driven precision medicine for development of HMBD-001 in HER3-driven cancers

Hummingbird Bioscience, a clinical-stage biotech company focused on developing revolutionary therapies for hard-to-drug targets, is collaborating with Tempus, an expert in artificial intelligence and precision medicine. This will drive the development of Hummingbird’s lead clinical program, HMBD-001, as it advances into clinical trials in HER3-driven cancers, including those that harbour… Read More

#Cancer Research #News

#AI / data analytics / healthtech / informatics #CRO

CRO undergoes digital data transformation: a case study

Jubilant Biosys improves data management, research productivity, and customer satisfaction with an informatics platform Jubilant Biosys, an international contract research organisation (CRO), has provided drug discovery and contract research services to the global pharmaceutical industry for 20 years. Headquartered in Noida, India with additional facilities in Bengaluru, the company’s 600-plus… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Biomarkers #Drug discovery

2020 overview for AI for drug discovery, biomarker development and advanced R&D

Deep Pharma Intelligence announces the release of a new, open-access 130-page analytical report and interactive analytics Dashboard: AI for Drug Discovery, Biomarker Development and Advanced R&D Landscape Overview 2020. This delivers advanced market intelligence, interactive mindmaps, benchmarking for companies, investors and technologies, competitive and SWOT analysis through the interactive IT-Platform and… Read More

#Editor's Choice #Market Reports #News